APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Glipizide

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Glipizide Market Analysis and Forecast 2026-2032

Report ID 173995340222 December 2025193 pages

Choose your research edition.

Industry ResearchGlipizide Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Glipizide Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Glipizide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Glipizide Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Glipizide Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Glipizide market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Glipizide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Glipizide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Glipizide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Glipizide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Glipizide include CCPC, TEVA, Lukang Pharma, United Laboratories, Jumpcan, Pfizer, PIDI, Disha Pharma and Jingfeng Zhiyao, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Glipizide, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Glipizide, also provides the sales of main regions and countries. Of the upcoming market potential for Glipizide, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Glipizide sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Glipizide market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Glipizide sales, projected growth trends, production technology, application and end-user industry.

Glipizide Segment by Company

CCPC

TEVA

Lukang Pharma

United Laboratories

Jumpcan

Pfizer

PIDI

Disha Pharma

Jingfeng Zhiyao

Yashica Pharma

Apotex

Glipizide Segment by Type

Glipizide Tablets

Glipizide Sustained Release Tablets

Others

Glipizide Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Glipizide Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glipizide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Glipizide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glipizide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Glipizide in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Glipizide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Glipizide sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Glipizide Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Glipizide Tablets Major Manufacturers Table 3. Glipizide Sustained Release Tablets Major Manufacturers Table 4. Others Major Manufacturers Table 5. Global Glipizide Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Pharmacies Major Manufacturers Table 7. Online Pharmacies Major Manufacturers Table 8. Retail Pharmacies Major Manufacturers Table 9. Glipizide Industry Trends Table 10. Glipizide Industry Drivers Table 11. Glipizide Industry Opportunities and Challenges Table 12. Glipizide Industry Restraints Table 13. Global Glipizide Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Glipizide Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Glipizide Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Glipizide Revenue Market Share by Region (2021-2026) Table 17. Global Glipizide Revenue Market Share by Region (2027-2032) Table 18. Global Glipizide Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (kg) Table 19. Global Glipizide Sales by Region (2021-2026) & (kg) Table 20. Global Glipizide Sales by Region (2027-2032) & (kg) Table 21. Global Glipizide Sales Market Share by Region (2021-2026) Table 22. Global Glipizide Sales Market Share by Region (2027-2032) Table 23. Global Glipizide Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Glipizide Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Glipizide Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Glipizide Sales Market Share by Manufacturers (2021-2026) Table 27. Global Glipizide Sales Price (US$/kg) of Manufacturers (2021-2026) Table 28. Global Glipizide Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Glipizide Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Glipizide Manufacturers, Product Type & Application Table 31. Global Glipizide Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Glipizide by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Glipizide Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Glipizide Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Glipizide Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Glipizide Revenue Market Share by Type (2021-2026) Table 38. Global Glipizide Revenue Market Share by Type (2027-2032) Table 39. Global Glipizide Sales by Type 2021 VS 2025 VS 2032 (kg) Table 40. Global Glipizide Sales by Type (2021-2026) & (kg) Table 41. Global Glipizide Sales by Type (2027-2032) & (kg) Table 42. Global Glipizide Sales Market Share by Type (2021-2026) Table 43. Global Glipizide Sales Market Share by Type (2027-2032) Table 44. Global Glipizide Price by Type (2021-2026) & (US$/kg) Table 45. Global Glipizide Price by Type (2027-2032) & (US$/kg) Table 46. Global Glipizide Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Glipizide Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Glipizide Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Glipizide Revenue Market Share by Application (2021-2026) Table 50. Global Glipizide Revenue Market Share by Application (2027-2032) Table 51. Global Glipizide Sales by Application 2021 VS 2025 VS 2032 (kg) Table 52. Global Glipizide Sales by Application (2021-2026) & (kg) Table 53. Global Glipizide Sales by Application (2027-2032) & (kg) Table 54. Global Glipizide Sales Market Share by Application (2021-2026) Table 55. Global Glipizide Sales Market Share by Application (2027-2032) Table 56. Global Glipizide Price by Application (2021-2026) & (US$/kg) Table 57. Global Glipizide Price by Application (2027-2032) & (US$/kg) Table 58. CCPC Company Information Table 59. CCPC Business Overview Table 60. CCPC Glipizide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 61. CCPC Glipizide Product Portfolio Table 62. CCPC Recent Development Table 63. TEVA Company Information Table 64. TEVA Business Overview Table 65. TEVA Glipizide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 66. TEVA Glipizide Product Portfolio Table 67. TEVA Recent Development Table 68. Lukang Pharma Company Information Table 69. Lukang Pharma Business Overview Table 70. Lukang Pharma Glipizide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 71. Lukang Pharma Glipizide Product Portfolio Table 72. Lukang Pharma Recent Development Table 73. United Laboratories Company Information Table 74. United Laboratories Business Overview Table 75. United Laboratories Glipizide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 76. United Laboratories Glipizide Product Portfolio Table 77. United Laboratories Recent Development Table 78. Jumpcan Company Information Table 79. Jumpcan Business Overview Table 80. Jumpcan Glipizide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 81. Jumpcan Glipizide Product Portfolio Table 82. Jumpcan Recent Development Table 83. Pfizer Company Information Table 84. Pfizer Business Overview Table 85. Pfizer Glipizide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 86. Pfizer Glipizide Product Portfolio Table 87. Pfizer Recent Development Table 88. PIDI Company Information Table 89. PIDI Business Overview Table 90. PIDI Glipizide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 91. PIDI Glipizide Product Portfolio Table 92. PIDI Recent Development Table 93. Disha Pharma Company Information Table 94. Disha Pharma Business Overview Table 95. Disha Pharma Glipizide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 96. Disha Pharma Glipizide Product Portfolio Table 97. Disha Pharma Recent Development Table 98. Jingfeng Zhiyao Company Information Table 99. Jingfeng Zhiyao Business Overview Table 100. Jingfeng Zhiyao Glipizide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 101. Jingfeng Zhiyao Glipizide Product Portfolio Table 102. Jingfeng Zhiyao Recent Development Table 103. Yashica Pharma Company Information Table 104. Yashica Pharma Business Overview Table 105. Yashica Pharma Glipizide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 106. Yashica Pharma Glipizide Product Portfolio Table 107. Yashica Pharma Recent Development Table 108. Apotex Company Information Table 109. Apotex Business Overview Table 110. Apotex Glipizide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 111. Apotex Glipizide Product Portfolio Table 112. Apotex Recent Development Table 113. North America Glipizide Revenue by Type (2021-2026) & (US$ Million) Table 114. North America Glipizide Revenue by Type (2027-2032) & (US$ Million) Table 115. North America Glipizide Sales by Type (2021-2026) & (kg) Table 116. North America Glipizide Sales by Type (2027-2032) & (kg) Table 117. North America Glipizide Sales Price by Type (2021-2026) & (US$/kg) Table 118. North America Glipizide Sales Price by Type (2027-2032) & (US$/kg) Table 119. North America Glipizide Revenue by Application (2021-2026) & (US$ Million) Table 120. North America Glipizide Revenue by Application (2027-2032) & (US$ Million) Table 121. North America Glipizide Sales by Application (2021-2026) & (kg) Table 122. North America Glipizide Sales by Application (2027-2032) & (kg) Table 123. North America Glipizide Sales Price by Application (2021-2026) & (US$/kg) Table 124. North America Glipizide Sales Price by Application (2027-2032) & (US$/kg) Table 125. North America Glipizide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. North America Glipizide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 127. North America Glipizide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 128. North America Glipizide Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 129. North America Glipizide Sales by Country (2021-2026) & (kg) Table 130. North America Glipizide Sales by Country (2027-2032) & (kg) Table 131. North America Glipizide Sales Price by Country (2021-2026) & (US$/kg) Table 132. North America Glipizide Sales Price by Country (2027-2032) & (US$/kg) Table 133. United States Glipizide Revenue (2021-2032) & (US$ Million) Table 134. Canada Glipizide Revenue (2021-2032) & (US$ Million) Table 135. Mexico Glipizide Revenue (2021-2032) & (US$ Million) Table 136. Europe Glipizide Revenue by Type (2021-2026) & (US$ Million) Table 137. Europe Glipizide Revenue by Type (2027-2032) & (US$ Million) Table 138. Europe Glipizide Sales by Type (2021-2026) & (kg) Table 139. Europe Glipizide Sales by Type (2027-2032) & (kg) Table 140. Europe Glipizide Sales Price by Type (2021-2026) & (US$/kg) Table 141. Europe Glipizide Sales Price by Type (2027-2032) & (US$/kg) Table 142. Europe Glipizide Revenue by Application (2021-2026) & (US$ Million) Table 143. Europe Glipizide Revenue by Application (2027-2032) & (US$ Million) Table 144. Europe Glipizide Sales by Application (2021-2026) & (kg) Table 145. Europe Glipizide Sales by Application (2027-2032) & (kg) Table 146. Europe Glipizide Sales Price by Application (2021-2026) & (US$/kg) Table 147. Europe Glipizide Sales Price by Application (2027-2032) & (US$/kg) Table 148. Europe Glipizide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 149. Europe Glipizide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 150. Europe Glipizide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 151. Europe Glipizide Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 152. Europe Glipizide Sales by Country (2021-2026) & (kg) Table 153. Europe Glipizide Sales by Country (2027-2032) & (kg) Table 154. Europe Glipizide Sales Price by Country (2021-2026) & (US$/kg) Table 155. Europe Glipizide Sales Price by Country (2027-2032) & (US$/kg) Table 156. Germany Glipizide Revenue (2021-2032) & (US$ Million) Table 157. France Glipizide Revenue (2021-2032) & (US$ Million) Table 158. U.K. Glipizide Revenue (2021-2032) & (US$ Million) Table 159. Italy Glipizide Revenue (2021-2032) & (US$ Million) Table 160. Russia Glipizide Revenue (2021-2032) & (US$ Million) Table 161. Spain Glipizide Revenue (2021-2032) & (US$ Million) Table 162. Netherlands Glipizide Revenue (2021-2032) & (US$ Million) Table 163. Switzerland Glipizide Revenue (2021-2032) & (US$ Million) Table 164. Sweden Glipizide Revenue (2021-2032) & (US$ Million) Table 165. Poland Glipizide Revenue (2021-2032) & (US$ Million) Table 166. China Glipizide Revenue by Type (2021-2026) & (US$ Million) Table 167. China Glipizide Revenue by Type (2027-2032) & (US$ Million) Table 168. China Glipizide Sales by Type (2021-2026) & (kg) Table 169. China Glipizide Sales by Type (2027-2032) & (kg) Table 170. China Glipizide Sales Price by Type (2021-2026) & (US$/kg) Table 171. China Glipizide Sales Price by Type (2027-2032) & (US$/kg) Table 172. China Glipizide Revenue by Application (2021-2026) & (US$ Million) Table 173. China Glipizide Revenue by Application (2027-2032) & (US$ Million) Table 174. China Glipizide Sales by Application (2021-2026) & (kg) Table 175. China Glipizide Sales by Application (2027-2032) & (kg) Table 176. China Glipizide Sales Price by Application (2021-2026) & (US$/kg) Table 177. China Glipizide Sales Price by Application (2027-2032) & (US$/kg) Table 178. Asia Glipizide Revenue by Type (2021-2026) & (US$ Million) Table 179. Asia Glipizide Revenue by Type (2027-2032) & (US$ Million) Table 180. Asia Glipizide Sales by Type (2021-2026) & (kg) Table 181. Asia Glipizide Sales by Type (2027-2032) & (kg) Table 182. Asia Glipizide Sales Price by Type (2021-2026) & (US$/kg) Table 183. Asia Glipizide Sales Price by Type (2027-2032) & (US$/kg) Table 184. Asia Glipizide Revenue by Application (2021-2026) & (US$ Million) Table 185. Asia Glipizide Revenue by Application (2027-2032) & (US$ Million) Table 186. Asia Glipizide Sales by Application (2021-2026) & (kg) Table 187. Asia Glipizide Sales by Application (2027-2032) & (kg) Table 188. Asia Glipizide Sales Price by Application (2021-2026) & (US$/kg) Table 189. Asia Glipizide Sales Price by Application (2027-2032) & (US$/kg) Table 190. Asia Glipizide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 191. Asia Glipizide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 192. Asia Glipizide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 193. Asia Glipizide Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 194. Asia Glipizide Sales by Country (2021-2026) & (kg) Table 195. Asia Glipizide Sales by Country (2027-2032) & (kg) Table 196. Asia Glipizide Sales Price by Country (2021-2026) & (US$/kg) Table 197. Asia Glipizide Sales Price by Country (2027-2032) & (US$/kg) Table 198. Japan Glipizide Revenue (2021-2032) & (US$ Million) Table 199. South Korea Glipizide Revenue (2021-2032) & (US$ Million) Table 200. India Glipizide Revenue (2021-2032) & (US$ Million) Table 201. Australia Glipizide Revenue (2021-2032) & (US$ Million) Table 202. Taiwan Glipizide Revenue (2021-2032) & (US$ Million) Table 203. Southeast Asia Glipizide Revenue (2021-2032) & (US$ Million) Table 204. SAMEA Glipizide Revenue by Type (2021-2026) & (US$ Million) Table 205. SAMEA Glipizide Revenue by Type (2027-2032) & (US$ Million) Table 206. SAMEA Glipizide Sales by Type (2021-2026) & (kg) Table 207. SAMEA Glipizide Sales by Type (2027-2032) & (kg) Table 208. SAMEA Glipizide Sales Price by Type (2021-2026) & (US$/kg) Table 209. SAMEA Glipizide Sales Price by Type (2027-2032) & (US$/kg) Table 210. SAMEA Glipizide Revenue by Application (2021-2026) & (US$ Million) Table 211. SAMEA Glipizide Revenue by Application (2027-2032) & (US$ Million) Table 212. SAMEA Glipizide Sales by Application (2021-2026) & (kg) Table 213. SAMEA Glipizide Sales by Application (2027-2032) & (kg) Table 214. SAMEA Glipizide Sales Price by Application (2021-2026) & (US$/kg) Table 215. SAMEA Glipizide Sales Price by Application (2027-2032) & (US$/kg) Table 216. SAMEA Glipizide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 217. SAMEA Glipizide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 218. SAMEA Glipizide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 219. SAMEA Glipizide Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 220. SAMEA Glipizide Sales by Country (2021-2026) & (kg) Table 221. SAMEA Glipizide Sales by Country (2027-2032) & (kg) Table 222. SAMEA Glipizide Sales Price by Country (2021-2026) & (US$/kg) Table 223. SAMEA Glipizide Sales Price by Country (2027-2032) & (US$/kg) Table 224. Brazil Glipizide Revenue (2021-2032) & (US$ Million) Table 225. Argentina Glipizide Revenue (2021-2032) & (US$ Million) Table 226. Chile Glipizide Revenue (2021-2032) & (US$ Million) Table 227. Colombia Glipizide Revenue (2021-2032) & (US$ Million) Table 228. Peru Glipizide Revenue (2021-2032) & (US$ Million) Table 229. Saudi Arabia Glipizide Revenue (2021-2032) & (US$ Million) Table 230. Israel Glipizide Revenue (2021-2032) & (US$ Million) Table 231. UAE Glipizide Revenue (2021-2032) & (US$ Million) Table 232. Turkey Glipizide Revenue (2021-2032) & (US$ Million) Table 233. Iran Glipizide Revenue (2021-2032) & (US$ Million) Table 234. Egypt Glipizide Revenue (2021-2032) & (US$ Million) Table 235. Key Raw Materials Table 236. Raw Materials Key Suppliers Table 237. Glipizide Distributors List Table 238. Glipizide Customers List Table 239. Research Programs/Design for This Report Table 240. Authors List of This Report Table 241. Secondary Sources Table 242. Primary Sources List of Figures Figure 1. Glipizide Image Figure 2. Global Glipizide Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Glipizide Market Size Share 2021 VS 2025 VS 2032 Figure 4. Glipizide Tablets Image Figure 5. Glipizide Sustained Release Tablets Image Figure 6. Others Image Figure 7. Global Glipizide Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Glipizide Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Pharmacies Image Figure 10. Online Pharmacies Image Figure 11. Retail Pharmacies Image Figure 12. Global Glipizide Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Glipizide Revenue (2021-2032) & (US$ Million) Figure 14. Global Glipizide Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Glipizide Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Glipizide Revenue Market Share by Region (2021-2032) Figure 17. Global Glipizide Sales (2021-2032) & (kg) Figure 18. Global Glipizide Sales by Region: 2021 VS 2025 VS 2032 (kg) Figure 19. Global Glipizide Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Glipizide Sales YoY (2021-2032) & (kg) Figure 21. Europe Glipizide Sales YoY (2021-2032) & (kg) Figure 22. China Glipizide Sales YoY (2021-2032) & (kg) Figure 23. Asia (Excluding China) Glipizide Sales YoY (2021-2032) & (kg) Figure 24. South America, Middle East and Africa Glipizide Sales YoY (2021-2032) & (kg) Figure 25. Global Glipizide Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Glipizide Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Glipizide Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Glipizide Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Glipizide Revenue Market Share by Type (2021-2032) Figure 31. Global Glipizide Sales by Type (2021 VS 2025 VS 2032) & (kg) Figure 32. Global Glipizide Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Glipizide Sales Market Share by Type (2021-2032) Figure 34. Global Glipizide Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Glipizide Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Glipizide Revenue Market Share by Application (2021-2032) Figure 37. Global Glipizide Sales by Application (2021 VS 2025 VS 2032) & (kg) Figure 38. Global Glipizide Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Glipizide Sales Market Share by Application (2021-2032) Figure 40. North America Glipizide Revenue Share by Type (2021-2032) Figure 41. North America Glipizide Sales Share by Type (2021-2032) Figure 42. North America Glipizide Revenue Share by Application (2021-2032) Figure 43. North America Glipizide Sales Share by Application (2021-2032) Figure 44. North America Glipizide Revenue Share by Country (2021-2032) Figure 45. North America Glipizide Sales Share by Country (2021-2032) Figure 46. Europe Glipizide Revenue Share by Type (2021-2032) Figure 47. Europe Glipizide Sales Share by Type (2021-2032) Figure 48. Europe Glipizide Revenue Share by Application (2021-2032) Figure 49. Europe Glipizide Sales Share by Application (2021-2032) Figure 50. Europe Glipizide Revenue Share by Country (2021-2032) Figure 51. Europe Glipizide Sales Share by Country (2021-2032) Figure 52. China Glipizide Revenue Share by Type (2021-2032) Figure 53. China Glipizide Sales Share by Type (2021-2032) Figure 54. China Glipizide Revenue Share by Application (2021-2032) Figure 55. China Glipizide Sales Share by Application (2021-2032) Figure 56. Asia Glipizide Revenue Share by Type (2021-2032) Figure 57. Asia Glipizide Sales Share by Type (2021-2032) Figure 58. Asia Glipizide Revenue Share by Application (2021-2032) Figure 59. Asia Glipizide Sales Share by Application (2021-2032) Figure 60. Asia Glipizide Revenue Share by Country (2021-2032) Figure 61. Asia Glipizide Sales Share by Country (2021-2032) Figure 62. SAMEA Glipizide Revenue Share by Type (2021-2032) Figure 63. SAMEA Glipizide Sales Share by Type (2021-2032) Figure 64. SAMEA Glipizide Revenue Share by Application (2021-2032) Figure 65. SAMEA Glipizide Sales Share by Application (2021-2032) Figure 66. SAMEA Glipizide Revenue Share by Country (2021-2032) Figure 67. SAMEA Glipizide Sales Share by Country (2021-2032) Figure 68. Glipizide Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Glipizide Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Glipizide Tablets
  • Glipizide Sustained Release Tablets
  • Others
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • CCPC
  • TEVA
  • Lukang Pharma
  • United Laboratories
  • Jumpcan
  • Pfizer
  • PIDI
  • Disha Pharma
  • Jingfeng Zhiyao
  • Yashica Pharma
  • Apotex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Glipizide Market by Type
  3. 1.2.1 Global Glipizide Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Glipizide Tablets
  5. 1.2.3 Glipizide Sustained Release Tablets
  6. 1.2.4 Others
  7. 1.3 Glipizide Market by Application
  8. 1.3.1 Global Glipizide Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital Pharmacies
  10. 1.3.3 Online Pharmacies
  11. 1.3.4 Retail Pharmacies
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Glipizide Market Dynamics
  1. 2.1 Glipizide Industry Trends
  2. 2.2 Glipizide Industry Drivers
  3. 2.3 Glipizide Industry Opportunities and Challenges
  4. 2.4 Glipizide Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Glipizide Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Glipizide Revenue by Region
  3. 3.2.1 Global Glipizide Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Glipizide Revenue by Region (2021-2026)
  5. 3.2.3 Global Glipizide Revenue by Region (2027-2032)
  6. 3.2.4 Global Glipizide Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Glipizide Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Glipizide Sales by Region
  9. 3.4.1 Global Glipizide Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Glipizide Sales by Region (2021-2026)
  11. 3.4.3 Global Glipizide Sales by Region (2027-2032)
  12. 3.4.4 Global Glipizide Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Glipizide Revenue by Manufacturers
  2. 4.1.1 Global Glipizide Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Glipizide Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Glipizide Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Glipizide Sales by Manufacturers
  6. 4.2.1 Global Glipizide Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Glipizide Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Glipizide Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Glipizide Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Glipizide Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Glipizide Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Glipizide Manufacturers, Product Type & Application
  13. 4.7 Global Glipizide Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Glipizide Market CR5 and HHI
  16. 4.8.2 2025 Glipizide Tier 1, Tier 2, and Tier 3
5 Glipizide Market by Type
  1. 5.1 Global Glipizide Revenue by Type
  2. 5.1.1 Global Glipizide Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Glipizide Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Glipizide Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Glipizide Sales by Type
  6. 5.2.1 Global Glipizide Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Glipizide Sales by Type (2021-2032) & (kg)
  8. 5.2.3 Global Glipizide Sales Market Share by Type (2021-2032)
  9. 5.3 Global Glipizide Price by Type
6 Glipizide Market by Application
  1. 6.1 Global Glipizide Revenue by Application
  2. 6.1.1 Global Glipizide Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Glipizide Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Glipizide Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Glipizide Sales by Application
  6. 6.2.1 Global Glipizide Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Glipizide Sales by Application (2021-2032) & (kg)
  8. 6.2.3 Global Glipizide Sales Market Share by Application (2021-2032)
  9. 6.3 Global Glipizide Price by Application
7 Company Profiles
  1. 7.1 CCPC
  2. 7.1.1 CCPC Company Information
  3. 7.1.2 CCPC Business Overview
  4. 7.1.3 CCPC Glipizide Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 CCPC Glipizide Product Portfolio
  6. 7.1.5 CCPC Recent Developments
  7. 7.2 TEVA
  8. 7.2.1 TEVA Company Information
  9. 7.2.2 TEVA Business Overview
  10. 7.2.3 TEVA Glipizide Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 TEVA Glipizide Product Portfolio
  12. 7.2.5 TEVA Recent Developments
  13. 7.3 Lukang Pharma
  14. 7.3.1 Lukang Pharma Company Information
  15. 7.3.2 Lukang Pharma Business Overview
  16. 7.3.3 Lukang Pharma Glipizide Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Lukang Pharma Glipizide Product Portfolio
  18. 7.3.5 Lukang Pharma Recent Developments
  19. 7.4 United Laboratories
  20. 7.4.1 United Laboratories Company Information
  21. 7.4.2 United Laboratories Business Overview
  22. 7.4.3 United Laboratories Glipizide Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 United Laboratories Glipizide Product Portfolio
  24. 7.4.5 United Laboratories Recent Developments
  25. 7.5 Jumpcan
  26. 7.5.1 Jumpcan Company Information
  27. 7.5.2 Jumpcan Business Overview
  28. 7.5.3 Jumpcan Glipizide Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Jumpcan Glipizide Product Portfolio
  30. 7.5.5 Jumpcan Recent Developments
  31. 7.6 Pfizer
  32. 7.6.1 Pfizer Company Information
  33. 7.6.2 Pfizer Business Overview
  34. 7.6.3 Pfizer Glipizide Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Pfizer Glipizide Product Portfolio
  36. 7.6.5 Pfizer Recent Developments
  37. 7.7 PIDI
  38. 7.7.1 PIDI Company Information
  39. 7.7.2 PIDI Business Overview
  40. 7.7.3 PIDI Glipizide Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 PIDI Glipizide Product Portfolio
  42. 7.7.5 PIDI Recent Developments
  43. 7.8 Disha Pharma
  44. 7.8.1 Disha Pharma Company Information
  45. 7.8.2 Disha Pharma Business Overview
  46. 7.8.3 Disha Pharma Glipizide Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Disha Pharma Glipizide Product Portfolio
  48. 7.8.5 Disha Pharma Recent Developments
  49. 7.9 Jingfeng Zhiyao
  50. 7.9.1 Jingfeng Zhiyao Company Information
  51. 7.9.2 Jingfeng Zhiyao Business Overview
  52. 7.9.3 Jingfeng Zhiyao Glipizide Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Jingfeng Zhiyao Glipizide Product Portfolio
  54. 7.9.5 Jingfeng Zhiyao Recent Developments
  55. 7.10 Yashica Pharma
  56. 7.10.1 Yashica Pharma Company Information
  57. 7.10.2 Yashica Pharma Business Overview
  58. 7.10.3 Yashica Pharma Glipizide Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Yashica Pharma Glipizide Product Portfolio
  60. 7.10.5 Yashica Pharma Recent Developments
  61. 7.11 Apotex
  62. 7.11.1 Apotex Company Information
  63. 7.11.2 Apotex Business Overview
  64. 7.11.3 Apotex Glipizide Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Apotex Glipizide Product Portfolio
  66. 7.11.5 Apotex Recent Developments
8 North America
  1. 8.1 North America Glipizide Market Size by Type
  2. 8.1.1 North America Glipizide Revenue by Type (2021-2032)
  3. 8.1.2 North America Glipizide Sales by Type (2021-2032)
  4. 8.1.3 North America Glipizide Price by Type (2021-2032)
  5. 8.2 North America Glipizide Market Size by Application
  6. 8.2.1 North America Glipizide Revenue by Application (2021-2032)
  7. 8.2.2 North America Glipizide Sales by Application (2021-2032)
  8. 8.2.3 North America Glipizide Price by Application (2021-2032)
  9. 8.3 North America Glipizide Market Size by Country
  10. 8.3.1 North America Glipizide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Glipizide Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Glipizide Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Glipizide Market Size by Type
  2. 9.1.1 Europe Glipizide Revenue by Type (2021-2032)
  3. 9.1.2 Europe Glipizide Sales by Type (2021-2032)
  4. 9.1.3 Europe Glipizide Price by Type (2021-2032)
  5. 9.2 Europe Glipizide Market Size by Application
  6. 9.2.1 Europe Glipizide Revenue by Application (2021-2032)
  7. 9.2.2 Europe Glipizide Sales by Application (2021-2032)
  8. 9.2.3 Europe Glipizide Price by Application (2021-2032)
  9. 9.3 Europe Glipizide Market Size by Country
  10. 9.3.1 Europe Glipizide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Glipizide Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Glipizide Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Glipizide Market Size by Type
  2. 10.1.1 China Glipizide Revenue by Type (2021-2032)
  3. 10.1.2 China Glipizide Sales by Type (2021-2032)
  4. 10.1.3 China Glipizide Price by Type (2021-2032)
  5. 10.2 China Glipizide Market Size by Application
  6. 10.2.1 China Glipizide Revenue by Application (2021-2032)
  7. 10.2.2 China Glipizide Sales by Application (2021-2032)
  8. 10.2.3 China Glipizide Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Glipizide Market Size by Type
  2. 11.1.1 Asia Glipizide Revenue by Type (2021-2032)
  3. 11.1.2 Asia Glipizide Sales by Type (2021-2032)
  4. 11.1.3 Asia Glipizide Price by Type (2021-2032)
  5. 11.2 Asia Glipizide Market Size by Application
  6. 11.2.1 Asia Glipizide Revenue by Application (2021-2032)
  7. 11.2.2 Asia Glipizide Sales by Application (2021-2032)
  8. 11.2.3 Asia Glipizide Price by Application (2021-2032)
  9. 11.3 Asia Glipizide Market Size by Country
  10. 11.3.1 Asia Glipizide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Glipizide Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Glipizide Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Glipizide Market Size by Type
  2. 12.1.1 SAMEA Glipizide Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Glipizide Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Glipizide Price by Type (2021-2032)
  5. 12.2 SAMEA Glipizide Market Size by Application
  6. 12.2.1 SAMEA Glipizide Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Glipizide Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Glipizide Price by Application (2021-2032)
  9. 12.3 SAMEA Glipizide Market Size by Country
  10. 12.3.1 SAMEA Glipizide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Glipizide Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Glipizide Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Glipizide Value Chain Analysis
  2. 13.1.1 Glipizide Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Glipizide Production Mode & Process
  6. 13.2 Glipizide Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Glipizide Distributors
  9. 13.2.3 Glipizide Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst